5G4R
BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-1 |
Synchrotron site | ESRF |
Beamline | ID23-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2014-09-24 |
Detector | DECTRIS PILATUS 6M |
Spacegroup name | P 1 |
Unit cell lengths | 47.444, 50.703, 61.981 |
Unit cell angles | 72.61, 71.36, 66.64 |
Refinement procedure
Resolution | 57.570 - 1.960 |
R-factor | 0.20237 |
Rwork | 0.200 |
R-free | 0.24031 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.010 |
RMSD bond angle | 1.353 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.6.0117) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 57.570 | 2.070 |
High resolution limit [Å] | 1.960 | 1.960 |
Rmerge | 0.060 | 0.180 |
Number of reflections | 33077 | |
<I/σ(I)> | 7.2 | 2.3 |
Completeness [%] | 93.9 | 93.9 |
Redundancy | 1.8 | 1.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 8.5 | 30% P550MME_P20K, 0.1M BUFFER 3, PH8.5, 10% ETHYLENE GLYCOLS |